These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

425 related articles for article (PubMed ID: 17933447)

  • 21. Alterations of lipid metabolism and gene expression in rat adipocytes during chronic olanzapine treatment.
    Minet-Ringuet J; Even PC; Valet P; Carpéné C; Visentin V; Prévot D; Daviaud D; Quignard-Boulange A; Tomé D; de Beaurepaire R
    Mol Psychiatry; 2007 Jun; 12(6):562-71. PubMed ID: 17211438
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Frequency of abnormal correlation between leptin and the body mass index during first and second generation antipsychotic drug treatment.
    Peña R; Marquina D; Serrano A; Elfakih Y; de Baptista EA; Carrizo E; Fernández V; Valery L; Teneud L; Baptista T
    Schizophr Res; 2008 Dec; 106(2-3):315-9. PubMed ID: 18835519
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Profiling of energy metabolism in olanzapine-induced weight gain in rats and its prevention by the CB1-antagonist AVE1625.
    Liebig M; Gossel M; Pratt J; Black M; Haschke G; Elvert R; Juretschke HP; Neumann-Haefelin C; Kramer W; Herling AW
    Obesity (Silver Spring); 2010 Oct; 18(10):1952-8. PubMed ID: 20168311
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The sex-dependent impact of chronic clozapine and haloperidol treatment on characteristics of the metabolic syndrome in a rat model.
    von Wilmsdorff M; Bouvier ML; Henning U; Schmitt A; Schneider-Axmann T; Gaebel W
    Pharmacopsychiatry; 2013 Jan; 46(1):1-9. PubMed ID: 22915487
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Recent evidence and potential mechanisms underlying weight gain and insulin resistance due to atypical antipsychotics.
    Volpato AM; Zugno AI; Quevedo J
    Braz J Psychiatry; 2013; 35(3):295-304. PubMed ID: 24142093
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Naltrexone does not prevent the weight gain and hyperphagia induced by the antipsychotic drug sulpiride in rats.
    Baptista T; Lacruz A; Acosta A; Colasante C; de Quijada M; de Mendoza S; Mendoza JM; Hernández L
    Appetite; 2000 Feb; 34(1):77-86. PubMed ID: 10744894
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A role for hypothalamic AMP-activated protein kinase in the mediation of hyperphagia and weight gain induced by chronic treatment with olanzapine in female rats.
    Sejima E; Yamauchi A; Nishioku T; Koga M; Nakagama K; Dohgu S; Futagami K; Kataoka Y
    Cell Mol Neurobiol; 2011 Oct; 31(7):985-9. PubMed ID: 21681559
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Antipsychotic-induced body weight gain: predictors and a systematic categorization of the long-term weight course.
    Gebhardt S; Haberhausen M; Heinzel-Gutenbrunner M; Gebhardt N; Remschmidt H; Krieg JC; Hebebrand J; Theisen FM
    J Psychiatr Res; 2009 Mar; 43(6):620-6. PubMed ID: 19110264
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Hyperphagia and increased meal size are responsible for weight gain in rats treated sub-chronically with olanzapine.
    Davoodi N; Kalinichev M; Korneev SA; Clifton PG
    Psychopharmacology (Berl); 2009 May; 203(4):693-702. PubMed ID: 19052729
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Olanzapine depot formulation in rat: a step forward in modelling antipsychotic-induced metabolic adverse effects.
    Skrede S; Martins L; Berge RK; Steen VM; López M; Fernø J
    Int J Neuropsychopharmacol; 2014 Jan; 17(1):91-104. PubMed ID: 23919889
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effects of the atypical antipsychotic olanzapine on reproductive function and weight gain in female rats.
    Fell MJ; Marshall KM; Williams J; Neill JC
    J Psychopharmacol; 2004 Jun; 18(2):149-55. PubMed ID: 15260902
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The atypical antipsychotic olanzapine causes weight gain by targeting serotonin receptor 2C.
    Lord CC; Wyler SC; Wan R; Castorena CM; Ahmed N; Mathew D; Lee S; Liu C; Elmquist JK
    J Clin Invest; 2017 Sep; 127(9):3402-3406. PubMed ID: 28805659
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Weight gain associated with clozapine, olanzapine and risperidone in children and adolescents.
    Fleischhaker C; Heiser P; Hennighausen K; Herpertz-Dahlmann B; Holtkamp K; Mehler-Wex C; Rauh R; Remschmidt H; Schulz E; Warnke A
    J Neural Transm (Vienna); 2007 Feb; 114(2):273-80. PubMed ID: 17109073
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Metabolic side effects induced by olanzapine treatment are neutralized by CB1 receptor antagonist compounds co-administration in female rats.
    Lazzari P; Serra V; Marcello S; Pira M; Mastinu A
    Eur Neuropsychopharmacol; 2017 Jul; 27(7):667-678. PubMed ID: 28377074
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The distinct effects of subchronic antipsychotic drug treatment on macronutrient selection, body weight, adiposity, and metabolism in female rats.
    Fell MJ; Anjum N; Dickinson K; Marshall KM; Peltola LM; Vickers S; Cheetham S; Neill JC
    Psychopharmacology (Berl); 2007 Oct; 194(2):221-31. PubMed ID: 17581744
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Betahistine ameliorates olanzapine-induced weight gain through modulation of histaminergic, NPY and AMPK pathways.
    Lian J; Huang XF; Pai N; Deng C
    Psychoneuroendocrinology; 2014 Oct; 48():77-86. PubMed ID: 24992721
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effects of antipsychotics with different weight gain liabilities on human in vitro models of adipose tissue differentiation and metabolism.
    Sertié AL; Suzuki AM; Sertié RA; Andreotti S; Lima FB; Passos-Bueno MR; Gattaz WF
    Prog Neuropsychopharmacol Biol Psychiatry; 2011 Dec; 35(8):1884-90. PubMed ID: 21840366
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Ameliorating antipsychotic-induced weight gain by betahistine: Mechanisms and clinical implications.
    Lian J; Huang XF; Pai N; Deng C
    Pharmacol Res; 2016 Apr; 106():51-63. PubMed ID: 26892184
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Chronic treatment with olanzapine via a novel infusion pump induces adiposity in male rats.
    Shobo M; Yamada H; Koakutsu A; Hamada N; Fujii M; Harada K; Ni K; Matsuoka N
    Life Sci; 2011 Apr; 88(17-18):761-5. PubMed ID: 21356217
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Betahistine effects on weight-related measures in patients treated with antipsychotic medications: a double-blind placebo-controlled study.
    Smith RC; Maayan L; Wu R; Youssef M; Jing Z; Sershen H; Szabo V; Meyers J; Jin H; Zhao J; Davis JM
    Psychopharmacology (Berl); 2018 Dec; 235(12):3545-3558. PubMed ID: 30382354
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 22.